Skip to content

Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy

Nurse Administered Propofol Sedation vs. Standard Therapy for Colonoscopy in Patients With IBD. A Randomised Controlled Study on Satisfaction and Adherence to Treatment Program.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01934088
Enrollment
130
Registered
2013-09-04
Start date
2014-01-31
Completion date
2015-09-30
Last updated
2015-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopy, Inflammatory Bowel Disease, Sedation

Keywords

Inflammatory Bowel disease, IBD, Sedation, NAPS, Propofol, Midazolam, Satisfaction, Feasibility

Brief summary

Sedation for endoscopy is a service more than a necessity. Therefore it should be patient driven. Patients with inflammatory bowel disease (IBD) undergoes life long endoscopic control. Therefore, satisfaction with the procedure experience is paramount for patients with IBD. Investigators wish to study the feasibility and the effect on patient experience of two drugs. Propofol administered by endoscopy nurses (NAPS) and conventional therapy with a combination of fentanyl and midazolam. Investigators hypothesize that patients sedated with propofol has a better procedure experience, that a well performed sedation equals a better experience and that NAPS is as feasible as fentanyl with midazolam sedation.

Interventions

DRUGPropofol
DRUGMidazolam
DRUGFentanyl

Sponsors

Copenhagen University Hospital at Herlev
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Inflammatory Bowel Disease (IBD) or suspected IBD * Planned Endoscopy * Candidate for propofol sedation * willingness to be randomized * Ability to complete questionnaire

Exclusion criteria

* Allergy to drugs * American Society of Anesthesiologists Class III * Body Mass Index \> 35 * Ventricular retention * Acute condition * Severe Chronic obstructive pulmonary disease * Sleep apnea * Potentially difficult airway or previous difficulty with anesthesia * Pregnancy * \<18 years

Design outcomes

Primary

MeasureTime frameDescription
SatisfactionParticipants will be interviewed when an Aldrete recovery score of 12 is achieved, an expected average of 2 hours after admissionSatisfaction points in a post procedure questionnaire.

Secondary

MeasureTime frameDescription
Pre-disposing factors for satisfaction with procedure and sedationAt admission to the hospital at time 0pre-operative questionnaire

Other

MeasureTime frameDescription
Correlation between quality of sedation and satisfactionAt the end of procedure, an expected average of 1 hour after admissionSedation efficacy is measured through use of a previously developed competency assessment tool. The quality of sedation score. The score is correlated with patient satisfaction
Feasibilty of methodparticipants will be followed for the duration of hospital stay, an expected average of 2 hoursTimespand from entering the OR until discharge. Safety parameters during sedation. Number of adverse events, number of airway interventions, number of rescue treatments

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026